Inflammation contributes to many chronic conditions. It is often associated with circulating
pro-inflammatory cytokines and immune cells. GLP-1 levels correlate with disease severity …

Glucagon and glucagon-like peptide-1 (GLP-1) are polypeptide hormones that are produced
by pancreatic α-cells and the intestine, respectively, whose main function is to control …

Glucagon-like peptide-1 (GLP-1) is a 30-amino acid hormone secreted by L cells in the
distal ileum, colon, and pancreatic α cells, which participates in blood sugar regulation by …

Hypoglycemia and hyperglycemia are both predictors for adverse outcome in critically ill
patients. Hyperinsulinemia is induced by inflammatory stimuli as a relevant mechanism for …

The glucagon-like peptides (glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2
(GLP-2)) are released from enteroendocrine cells in response to nutrient ingestion. GLP-1 …

Gut peptides exert diverse effects regulating satiety, gastrointestinal motility and acid
secretion, epithelial integrity, and both nutrient absorption and disposal. These actions are …

Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have emerged as promising
therapeutic agents with potent anti-inflammatory properties and diverse clinical implications …

The glucagon-like peptide 2 (GLP-2) is an intestinotrophic hormone with growth promoting
and anti-inflammatory actions. However, the full biological functions of GLP-2 and the …

Glucagon-like peptide 2 (GLP-2) is an important intestinal growth factor with anti-
inflammatory activity. We hypothesized that GLP-2 decreases mucosal inflammation and the …

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) exert anti-inflammatory effects
relevant to the chronic complications of type 2 diabetes. Although GLP-1RAs attenuate T cell …